Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer

Clinical Cancer Research

Volumn 12, Issue 20 PART 1, 2006, Pages 5987-5993

  Pootrakul, Llana ^a   Datar, Ram H ^a   Shi, Shan Rong ^a   Cai, Jie ^b   Hawes, Debra ^a   Groshen, Susan G ^b   Lee, Amy S ^c   Cote, Richard J ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CHAPERONE; CHAPERONE GRP78; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ANDROGEN THERAPY; ARTICLE; CANCER CELL; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CASTRATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR CLASSIFICATION;

COHORT STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; MALE; MOLECULAR CHAPERONES; NEOPLASM STAGING; ORCHIECTOMY; PROSTATIC NEOPLASMS; STRESS; TUMOR CELLS, CULTURED;

EID: 33750706551     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0133     Document Type: Article

References (42)

1. Shiu RPC, Pouyssegur J, Pastan I. Glucose depletion for the induction of two transformation-sensitive membrane proteins in Rous sarcoma virus-transformed chick embryo fibroblasts. PNAS 1977;74:3840-4.
2. Lee AS. Coordinated regulation of a set of genes by glucose and calcium ionophores in mammalian cells. TIBS 1987;12:20-3.
3. Haas IG, Wabl M. Immunoglobulin heavy chain binding protein. Nature 1983;306:387-9.
4. Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev in Euk Gene Exp 1994;4:1-18.
5. Dorner AJ, Krane MG, Kaufman RJ. Reduction of Endogenous GRP78 levels improves secretion of a heterologous protein in CHO cells. MCB 1988;8:4063-70.
6. Lee AS. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 2005;35:373-81.
7. Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 2003;278:20915-24.
8. Rao RV, Peel A, Logvinova A, et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Letters 2002;514:122-8.
9. Miyake H, Hara I, Arakawa S, Kamidono S. Stress protein GRP78 prevents apoptosis induced by calcium ionophore, ionomycin, but not by glycosylation inhibitor, tunicamycin, in human prostate cancer cells. J Cell Biochem 2000;77:396-408.
10. Lee AS. The glucose-regulated proteins: stress induction and clinical applications. TIBS 2001;26:504-10.
11. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes and Devel 1999;13:1211-33.
12. Jamora C, Dennert G, Lee AS. Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. PNAS1996;93:7690-4.
13. Dong D, Ko B, Baumeister P, et al. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res 2005;65:5785-91.
14. Mintz PJ, Kim J, Do K, et al. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 2003;21:57-63.
15. r 78,000 glucose-regulated protein in chemically and radiation-transformed C3H 10T1/2 mouse embryo cells. Cancer Res 1987;47:6220-4.
16. Bini L, Magi B, Marzocchi B, et al. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 1997;18:2832-41.
17. Gazit G, Lu J, Lee AS. De-regulation of GRP stress protein expression in human breast cancer cell lines. Br Ca Res Tr 1999;54:135-46.
18. Fernandez PM, Tabbara SO, Jacobs LK, et al. Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Br Ca Res Tr 2000;59:15-26.
19. International Union Against Cancer. Urological tumours: Prostate. In: TNM classification of malignant tumours, 4th edition. Hermanek P and Sobin LH, editors. New York: John Wiley & Sons: 1992. p. 141-4.
20. Fradet Y. The role of neoadjuvant androgen deprivation prior to radical prostatectomy. Urol Clin North Am 1996;23:575-85.
21. Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In: Urologic pathology: the prostate. Tannenbaum M, editor. Philadelphia: Lea & Febiger; 1977. p. 171-3.
22. Shi SR, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 1997;45:327-43.
23. Craft N, Shostak Y, Carey M, Sawyers CL. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999;5:280-5.
24. Bauer KD, de laTorre-Bueno J, Diel IJ, et al. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging. Clin Cancer Res 2000;6:3552-9.
25. Wang S, Saboorian MH, Frenkel EP, et al. Assessment of HER-2/neu status in breast cancer. Am J Clin Path 2001;116:495-503.
26. Shah RB, Mehra R, Chinnaiyan AM, et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res 2004;64:9209-16.
27. Messersmith W, Oppenheimer D, Peralba J, et al. Assessment of epidermal growth factor receptor (EGFR) signaling in paired colorectal cancer and normal colon tissue samples using computer-aided immunohistochemical analysis. Cancer Biol Ther 2005;5:70-5.
28. Craft N, Chhor C, Tran C, et al. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res 1999;59:5030-6.
29. Shen J, Hughes C, Chao C, et al. Coinduction of glucose regulated proteins and doxorubicin resistance in Chinese hamster cells. PNAS USA 1987;84:3278-82.
30. 2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulated PAK-2-dependent activation of LIMK. JBC 2005;280:26278-86.
31. So A, Gleave M, Hurtado-Col A, Nelson C. Mechanisms of the development of androgen independence in prostate cancer. World J Urol 2005;23:1-9.
32. Shi Y, Chatterjee SJ, Brands FH, et al. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations. Br J Urol Int 2006;97:170-8.
33. Munro S, Pelham HRB. An Hsp70-like protein in the ER: Identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 1986;46:291-300.
34. Zhao Z, Ma Q, Xu C. Abrogation of heat-shock protein (HSP) 70 expression induced cell growth inhibition and apoptosis in human androgen-independent prostate cancer cell line PC-Sm. Asian J Androl 2004;6:319-24.
35. Rocchi P, So A, Kojima S, et al. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res 2004;64:6595-602.
36. Cornford PA, Dodson AR, Parsons KF, et al. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000;60:7099-105.
37. Neckers L. Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer. Clin Cancer Res 2002;8:962-6.
38. Solit DB, Zheng FF, Drobjnak M, et al. 17-Allylamino-17- demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. Clin Cancer Res 2002;8:986-93.
39. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev 2001;1:34-45.
40. Li J, Lee AS. Stress induction of Grp78/BiP and its role in cancer. Curr Mol Med 2006;6:45-54.
41. Arap MA, Lahdenranta J, Mintz PJ, et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 2004;6:275-84.
42. Misra UK, Gonzalez-Gronow M, Gawdi G, Hart JP, Johnson CE, Pizzo SV. The role of Grp78 in α 2-macroglobulin-induced signal transduction. Evidence from RNA interference that the low density lipoprotein receptor-related protein is associated with, but not necessary for, GRP 78-mediated signal transduction. J Biol Chem 2002;277:42082-7.